What is she best known for?
The fields of study she is best known for:
- Gene
- Immune system
- Cancer
Her primary areas of study are Immunology, Immune system, Cancer research, Apoptosis and Inflammation.
Her Immunology research is multidisciplinary, incorporating perspectives in Receptor, microRNA and Cellular differentiation.
Her research investigates the connection between Immune system and topics such as Cannabinoid receptor that intersect with problems in Cannabinoid and Endocannabinoid system.
Her Cancer research research incorporates elements of Aryl hydrocarbon receptor, Latent Virus, Viral load, AMPK and Protein kinase C.
Her studies deal with areas such as Concanavalin A, Endocrinology and Internal medicine as well as Apoptosis.
Her Inflammation research is multidisciplinary, relying on both T cell, Colitis, Resveratrol and Myeloid-derived Suppressor Cell.
Her most cited work include:
- Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease (241 citations)
- Cannabinoids as novel anti-inflammatory drugs (233 citations)
- Role of cytokines as a double-edged sword in sepsis. (225 citations)
What are the main themes of her work throughout her whole career to date?
Mitzi Nagarkatti spends much of her time researching Immunology, Inflammation, Cancer research, Immune system and Internal medicine.
Her Receptor research extends to the thematically linked field of Immunology.
The Inflammation study combines topics in areas such as Adipose tissue, Downregulation and upregulation, Colitis and Cytokine.
Her Cancer research research includes themes of Apoptosis, Transfection, microRNA, Myeloid-derived Suppressor Cell and Resveratrol.
Mitzi Nagarkatti has included themes like Cannabinoid, Pharmacology, Antigen and Cannabinoid receptor in her Immune system study.
As a part of the same scientific family, Mitzi Nagarkatti mostly works in the field of Internal medicine, focusing on Endocrinology and, on occasion, CD8 and Nonalcoholic fatty liver disease.
She most often published in these fields:
- Immunology (42.41%)
- Inflammation (29.51%)
- Cancer research (28.37%)
What were the highlights of her more recent work (between 2018-2021)?
- Inflammation (29.51%)
- Cancer research (28.37%)
- Pharmacology (13.75%)
In recent papers she was focusing on the following fields of study:
Mitzi Nagarkatti mostly deals with Inflammation, Cancer research, Pharmacology, Immune system and FOXP3.
Her research integrates issues of Gut flora, Downregulation and upregulation, Colitis and Inflammatory bowel disease in her study of Inflammation.
Mitzi Nagarkatti has researched Cancer research in several fields, including Apoptosis, T cell, Histone deacetylase, Cell type and Resveratrol.
The study incorporates disciplines such as Proinflammatory cytokine, Neuroinflammation, Delta-9-tetrahydrocannabinol and Cannabidiol in addition to Pharmacology.
Her study on Immune system is covered under Immunology.
Her FOXP3 study also includes
- Cell biology, CXC chemokine receptors, Myeloid-derived Suppressor Cell, Thymic involution and Antigen most often made with reference to Aryl hydrocarbon receptor,
- Transfection and related T cell differentiation.
Between 2018 and 2021, her most popular works were:
- Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells. (38 citations)
- Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice (30 citations)
- The role of gut microbiota in shaping the relapse-remitting and chronic-progressive forms of multiple sclerosis in mouse models. (25 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cancer
Her primary areas of investigation include Inflammation, Gut flora, Downregulation and upregulation, Cancer research and Apoptosis.
Her biological study spans a wide range of topics, including Immune system, Colitis, Resveratrol and Dysbiosis.
Her Downregulation and upregulation research is multidisciplinary, incorporating elements of Cytokine, Neuroblastoma and Cannabinoid receptor.
Her Cancer research study combines topics in areas such as Cell culture, Transfection, CXC chemokine receptors, Chemokine receptor and Myeloid-derived Suppressor Cell.
In her research on the topic of Apoptosis, Cannabidiol and Pharmacology is strongly related with Experimental autoimmune encephalomyelitis.
Her Autoimmune encephalitis study is related to the wider topic of Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
